Michael Hennig
leadXpro AG, Villigen, Switzerland
Biography
Michael Hennig is a drug discovery research manager with 22 years of experience in pharmaceutical industry. He co-founded and is CEO and Chairman of the board of leadXpro, an emerging biotech company and spin-out of the Paul Scherrer Institute (ETH, Switzerland) that is dedicated to structure based drug discovery of membrane protein targets. Formerly he worked 20 years at Roche research Basel, Global Head and Principle Leader of discovery technologies with responsibility for structure based drug discovery, protein science, assay development and HTS, corporate compound library, stem cell platform. In addition, he is guest Professor at the University of Basel in structural biology, gives lecture series in pharmacy, is author of >75 paper and lecturer at conferences, inventor of 8 patents in areas of technology, discovery and formulation of drug substances.
Abstract
Abstract : Structure Based Drug Discovery on Membrane Protein Targets: New developments and advancements